| Carbonic anhydrase inhibitor | |
|---|---|
| Drug class | |
 | |
| Class identifiers | |
| Use | Glaucoma |
| ATC code | S01EC |
| Biological target | Carbonic anhydrase |
| Clinical data | |
| Drugs.com | Drug Classes |
| External links | |
| MeSH | D002257 |
| Legal status | |
| In Wikidata | |
Carbonic anhydrase inhibitors are a class of pharmaceuticals thatsuppress the activity ofcarbonic anhydrase. Their clinical use has been established as anti-glaucoma agents,diuretics,antiepileptics, in the management ofmountain sickness, gastric and duodenalulcers,idiopathic intracranial hypertension,neurological disorders, orosteoporosis.[1][2][3]
Members of carbonic anhydrase inhibitor group of medications include:acetazolamide,dorzolamide,methazolamide,brinzolamide,dichlorphenamide.
Carbonic anhydrase inhibitors are primarily used for the treatment of glaucoma. They may also be used to treat seizure disorder and acutemountain sickness. Because they encourage solubilization and excretion of uric acid, they can be used in the treatment of gout.[4]
Inhibition of carbonic anhydrase II in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport.[citation needed]
Carbonic anhydrase inhibitors as weak diuretics and saluretics (promotors of sodium chloride excretion). Acting principally upon theproximal tubule of the nephron, CAIs incompletely inhibit bicarbonate reabsorption by reducing conversion of carbonic acid to CO2 at the liminal membrane, reducing intracellular conversion of CO2 back to carbonic acid after CO2 has diffused across the membrane from the lumen, and reducing transport of Na+ and bicarbonate out of the cell across the basal membrane.[5] Lowered bicarbonate reabsorption results in decreased activity of the apical Na+/H+ exchanger which mediates diuresis.[citation needed] The reduced NaCl reabsorption in the proximal tubule is however partially compensated by increased NaCl reabsorption in more distal portions of the nephron (namely thethick ascending limb of loop of Henle). The diuretic effect of CAIs is therefore middling, and the principal effect is rather urinary loss of bicarbonate and consequent decrease of blood pH (promotion of metabolic acidosis).[5]
Carbonic anhydrase inhibitors may be used to reduce the production of cerebrospinal fluid (CSF) in the brain. For instance, acerebrospinal fluid leak may initially be treated medically with this medication to reduce the volume of leakage, and promote healing of the fistula. Similarly, inIdiopathic intracranial hypertension, reduction of CSF production by thechoroid plexi may reduce intracranial pressures and reduce symptoms of elevatedintracranial pressure such as retroorbital headaches and loss of vision. The mechanism is thought to involve inhibition of carbonic anhydrase (CA) within the choroidal epithelial cells, reducing the production of protons which are necessary for the osmotic transport of water and ions which constitute CSF.
Acetazolamide is effective in the treatment of most types of seizures, including generalized tonic-clonic and focal seizures and especially absence seizures, although it has limited utility because tolerance develops with chronic use. The drug is occasionally used on an intermittent basis to prevent seizures incatamenial epilepsy.[6]
The sulfur-containing antiseizure and antimigraine drugtopiramate is a weak inhibitor of carbonic anhydrase, particularly subtypes II and IV.[7] Whether carbonic anhydrase inhibition contributes to its clinical activity is not known. In rare cases, the inhibition of carbonic anhydrase may be strong enough to causemetabolic acidosis of clinical importance.Zonisamide is another sulfur containing antiseizure drug that weakly inhibits carbonic anhydrase.
Sultiame is also an example of an anticonvulsant drug of this class.
At high altitude, the partial pressure of oxygen is lower and people have to breathe more rapidly to get adequate oxygen. When this happens, the partial pressure of CO2 in the lungs (pCO2) decreases (is "blown off"), causing arespiratory alkalosis. This would normally be compensated by the kidney excreting bicarbonate and causing compensatorymetabolic acidosis, but this homeostatic adaptation takes several days to develop. Carbonic anhydrase inhibitors can therefore be used to hasten (or, rather, mimic)acclimatization as these inhibit renal bicarbonate reabsorption, thus counteracting the altitude-related respiratory alkalosis.[8] Carbonic anhydrase inhibitors have also been shown to improvechronic mountain sickness.[9]
Loss of bicarbonate may result inmetabolic acidosis.[11]
Ellagitannins extracted from the pericarps ofPunica granatum, the pomegranate, such aspunicalin,punicalagin,granatin B,gallagyldilactone,casuarinin,pedunculagin andtellimagrandin I, are carbonic anhydrase inhibitors.[12]